Company :: Welcome to the ABL, SA Website

ABL Enters into an International Distribution and Licence Agreement for the virco®TYPE HIV Resistance Interpretation System Through ABL's TherapyEdge-ViroScore™ Platform


  • LUXEMBOURG--(BUSINESS WIRE)--Advanced Biological Laboratories (ABL) is pleased to announce its recent signature of a non-exclusive international distribution agreement (excluding United States, Australia, Canada and United Kingdom) of virco®TYPE HIV-1, Belgium-based Virco BVBA's HIV resistance interpretation system.

  • ABL will offer virco®TYPE HIV-1 through its electronic medical record and decision support system TherapyEdge™ HIV. virco®TYPE HIV-1 results (raw data and report) will be available together with full patient's details and will support the healthcare providers' virological and clinical decisions taking care of HIV-infected patients experiencing virological failure and HIV drug resistance.


See the press releaseDownload PDF

BioHealth


ABL Licensed CRP-Santé COMET Subtyping Tool.


Advanced Biological Laboratories (ABL) S.A. and Luxembourg Centre de Recherche Public pour la Santé CRP-Santé announced a non-exclusive licensing and distribution agreement to implement CRP-Santé COMET subtyping tool on ABL TherapyEdge Platform.


See the press releaseDownload PDF

BioHealth


FibroMeters : the most reliable tests of liver fibrosis.


FibroMeters are the best performing tests for the diagnosis of significant fibrosis. A FibroMeter specific for viral cirrhosis provides very high diagnostic performance. The combination of FibroMeter and Fibroscan significantly improves the diagnostic performance of each test.


See the presentation Download PDF


ABL is pleased to announce the presentation of the Spanish version of TherapyEdge & ViroScore at the GeSIDA congress that will be held in Madrid from the 21st to the 24th of October 2009.

  • TherapyEdge & RIS (Red Española de Investigación en SIDA) licensing partnership
    TherapyEdge se complace de anunciar la disponibilidad de la versión 2009 del algoritmo de interpretación de resistencia a los fármacos para el VIH de la RIS (www.retic-ris.net), integrada dentro del paquete TherapyEdge - ViroScore (versión 3.9.2). Ahora, los usuarios de TherapyEdge - ViroScore, se beneficiarán de la habilidad de los expertos españoles en los términos de la determinación de la resistencia del VIH, además de los otros 6 algoritmos internacionales de interpretación de resistencia a los fármacos para el VIH (Stanford University, ANRS French resistance interpretation rules, Rega institute, Detroit Medical Center, RenaGeno from Brazil and CHL from Luxemburg).

  • TherapyEdde y Roche Diagnostics SL partnership
    TherapyEdge y Roche Diagnostics SL han establecido un acuerdo de colaboración en España para la promoción de soluciones conjuntas destinadas al diagnóstico, seguimiento y tratamiento de los pacientes infectados con VIH."


GeSIDA

See the brochure Download PDF

See the presentation Download PDF


ABL is pleased to announce that Centro de Genomas® is as of Oct 15th 2009 the TherapyEdge local agent in Brazil and will present the TherapyEdge and ViroScore products at the "XVI Congresso Brasileiro de Infectologia" which will be held from October the 18th to October the 21st at Maceió, BRAZIL.


Genomas

See the brochure Download PDF


TherapyEdge ABL SA and BioLiveScale SA are pleased to announce a co-sponsoring of the next Symposium on the management of HIV/HBV-HCV co-infections.


BLS

See the presentation Download PDF


ABL SA is pleased to announce the United States Patent & Trademark Office (USPTO) issued on September 15th 2009, the Ex Parte Reexamination Certificate for the Barry et al US patent N° 6,081,786


See the Ex Parte Reexamination Certificate here Download PDF


ABL and Evivar Medical enter into Agreements to form a global strategic partnership and IP cross-licensing for disease management and personalized healthcare of Hepatitis B and HIV infections


Evivar

See The Press Release Here Download PDF

See The Press Release Presentation Here Download PDF


BioHealth: newsletter 1
The Cluster of Health Sciences & Technologies - Luxembourg


BioHealth

See The Newsletter Here Download PDF

Link 1 : Luxinnovation

Link 2 : Portail Luxembourgeois de l'Innovation et de la Recherche


ABL, SA :: Solutions for HIV Disease Management

TherapyEdge and RightToCare Successfully Launch the New TherapyEdgeTM Down Referral Software Patient Management System


RightToCare

See The Press Release Here Download PDF


Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.


VirAlliance

See The Press Release Here Download PDF


TherapyEdge (ABL group) and TCELS To Cooperate for the National HIV/AIDS Surveillance Program in Thailand Using The TherapyEdge-ViroScoreTM System


Tcels

See The Press Release Here Download PDF


TherapyEdge, ABL and MSH Enter into Agreement to Collaborate on Integration of Software for the Management of HIV, Tuberculosis


MSH

See The Press Release Here Download PDF


Advanced Biological Laboratories (ABL) and PharmAccess Foundation Enter Licensing Agreement to Support the PASER Study


PharmAccess

See The Press Release Here Download PDF


ViroScore Suite LogoViroScoreTM Suite

ViroScoreTM Suite is a HIV resistance interpretation system and sequence database for HIV physicians and researchers. Now used in over 36 countries to optimize the selection of HIV Anti-Retroviral Therapy.

ViroScoreTM Suite: Optimize Your Choice

ViroScore<SUP><SMALL>TM</SMALL></SUP> Suite Logo

Download Sample ViroScoreTM Reports :: ABL Licenses Stanford AlgorithmDownload PDF


picture of doctor with PDATherapyEdge-HIV

TherapyEdge-HIV is a clinical point of care health record and HIV decision support system. USAID PEPFAR and WHO reporting built in to the highly customizable system.

TherapyEdge-HIV Solutions for:

  • HIV Clinics: Improve quality of care and reduce patient workup times with integrated Decision Support
  • GO's and NGO's: Agregate data from remote and connected sites at a local, regional, country and continent levels.
  • HIV Reseachers: Easily gather, agregate and analyze clinical and lab (including sequence and mutation data) for outcomes analysis.
  • Pharmacuetical and Diagnostic Companies: Improve your Phase IV and ongoing research with valuable clinical research database tools.


To contact a sales representative, visit the Contact Us page and fill out the contact form. You can also visit the Partner Page to find a local or regional ABL Authorized Reseller.